These findings indicated that high expression of RUVBL1, HSPA9, and XPO1 was significantly associated with the presence of any of the trio of activated oncogenes in the patient samples of colon and pancreatic cancers. The gene discussed is XPO1; the disease is pancreatic neoplasm.